Loading...
Heart failure hospitalization risk associated with use of two classes of oral antidiabetic medications: an observational, real-world analysis
BACKGROUND: Newer oral antidiabetic drug classes are expanding treatment options for type 2 diabetes mellitus (T2DM); however, concerns remain. The objective was to assess relative risk of heart failure hospitalization of sodium–glucose co-transporter-2 (SGLT2) and dipeptidyl peptidase-4 (DPP4) inhi...
Na minha lista:
| Udgivet i: | Cardiovasc Diabetol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5535291/ https://ncbi.nlm.nih.gov/pubmed/28756774 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-017-0575-x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|